Seroatlas · Human Serome Atlas

FAS

Tumor necrosis factor receptor superfamily member 6

Also known as: APO-1, APT1, CD95, FAS1, TNFRSF6, TNR6_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P25445
Gene
FAS
Ensembl
ENSG00000026103
Chromosome
10
Canonical length
335 aa
Protein class
Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
Subcellular location
Nuclear bodies,Plasma membrane,Cytosol
Secretome location
Secreted to blood

OverviewNCBI Gene

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. Several alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated mRNA decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform. [provided by RefSeq, Mar 2011]

Canonical amino-acid sequenceUniProt

335 residues, UniProt reviewed canonical sequence.

>P25445|FAS
     1  MLGIWTLLPL VLTSVARLSS KSVNAQVTDI NSKGLELRKT VTTVETQNLE GLHHDGQFCH
    61  KPCPPGERKA RDCTVNGDEP DCVPCQEGKE YTDKAHFSSK CRRCRLCDEG HGLEVEINCT
   121  RTQNTKCRCK PNFFCNSTVC EHCDPCTKCE HGIIKECTLT SNTKCKEEGS RSNLGWLCLL
   181  LLPIPLIVWV KRKEVQKTCR KHRKENQGSH ESPTLNPETV AINLSDVDLS KYITTIAGVM
   241  TLSQVKGFVR KNGVNEAKID EIKNDNVQDT AEQKVQLLRN WHQLHGKKEA YDTLIKDLKK
   301  ANLCTLAEKI QTIILKDITS DSENSNFRNE IQSLV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FAS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.43
Highest tissue expression
16 nTPM

Expression across tissuesHPA

Tissue

  • lung: 16 nTPM
  • ovary: 15 nTPM
  • adrenal gland: 14 nTPM
  • liver: 12 nTPM
  • bone marrow: 11 nTPM
  • adipose tissue: 9 nTPM

Single-cell type

  • neutrophils: 161 nCPM
  • epididymal basal cells: 144 nCPM
  • fallopian secretory cells: 108 nCPM
  • mesothelial cells: 107 nCPM
  • alveolar cells type 1: 104 nCPM
  • epicardial cells: 96 nCPM

Immune cell

  • neutrophil: 101 nTPM
  • T-reg: 91 nTPM
  • basophil: 41 nTPM
  • eosinophil: 32 nTPM
  • memory CD4 T-cell: 25 nTPM
  • memory CD8 T-cell: 21 nTPM

Brain region

  • medulla oblongata: 8.8 nTPM
  • cerebral cortex: 7.5 nTPM
  • white matter: 7.4 nTPM
  • amygdala: 7 nTPM
  • pons: 7 nTPM
  • thalamus: 7 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FAS.

Disease | AllUniProt

Conditions FAS is implicated in, by any mechanism.

Disease | GeneticClinVar

119 pathogenic / likely-pathogenic of 518 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

ReferencesPubMed · IEDB

Publications for FAS from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

12 publications

Show 7 more

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.44
gnomAD pLI
0.81
gnomAD missense Z
1.23
DepMap mean gene effect
-0.13
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FAS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FAS as an antibody target. Whether an autoantibody or antibody against FAS could matter depends on whether native FAS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FAS is annotated at the cell surface, where native FAS is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label FAS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FAS. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...